Back
PAR Technology 10K Form
Buy
63
PAR
PAR Technology
Last Price:
78.85
Seasonality Move:
9.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-09 | 10Q | PAR/PAR Technology Quarterly |
2023-08-09 | 10Q | PAR/PAR Technology Quarterly |
2023-05-10 | 10Q | PAR/PAR Technology Quarterly |
2022-11-09 | 10Q | PAR/PAR Technology Quarterly |
2022-08-09 | 10Q | PAR/PAR Technology Quarterly |
2022-05-10 | 10Q | PAR/PAR Technology Quarterly |
Receive PAR News And Ratings
See the #1 stock for the next 7 days that we like better than PAR
PAR Financial Statistics
Sales & Book Value
Annual Sales: | $415.82M |
---|---|
Cash Flow: | $7.08M |
Price / Cash Flow: | 0 |
Annual Sales: | $19.08 |
Price / Book: | 4.03 |
Profitability
EPS (TTM): | -0.25000 |
---|---|
Net Income (TTM): | $-2.56M |
Gross Margin: | $98.31M |
Return on Equity: | -0.52% |
Return on Assets: | -0.26% |
PAR Technology Earnings Forecast
Key PAR Technology Financial Ratios
- The Gross Profit Margin over the past 40 years for PAR is 23.64%.
- The Selling, General & Administrative Expenses for PAR have been equal to 25.85% of Gross Profit Margin.
- The Research & Development expenses have been 14.03% of Revenue.
- The Interest Expense is -9.94% of Operating Income.
- The Net Earning history of PAR is -16.77% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 23 years.
PAR Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Electronic Equipment, Instruments & Components |
Sector: | Information Technology |
Current Symbol: | PAR |
CUSIP: | 698884 |
Website: | partech.com |
Debt
Debt-to-Equity Ratio: | 0.67 |
---|---|
Current Ratio: | 2.13 |
Quick Ratio: | 1.63 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 620.32 |
PAR Technical Analysis vs Fundamental Analysis
Buy
63
PAR Technology (PAR)
is a Buy
Is PAR Technology a Buy or a Sell?
-
PAR Technology stock is rated a Buy
The current PAR Technology [PAR] share price is $76.92. The Score for PAR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.